SCHEMBL4934191

SCHEMBL4934191

N#Cc1cc(COc2c(Br)cc(C(=O)NCC(=O)O)cc2Br)cc(NC2CCC2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 4/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
THRA P10827 3/20 0.35
THRB P10828 3/20 0.35
DHODH Q02127 2/20 0.35
MRGPRX4 Q96LA9 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
ITGB3 P05106 1/20 0.33
ITGA2B P08514 1/20 0.33
PTPN1 P18031 3/20 0.33
TAOK1 Q7L7X3 1/20 0.33
TAOK3 Q9H2K8 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
FLT1 P17948 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5718269 0.91 THRA (0.40) EGLN1MEN1KMT2ATHRATHRB
SCHEMBL4929677 0.91 MRGPRX4 (0.38) EGLN1MRGPRX4PDE4APDE4BPDE4C
SCHEMBL5717898 0.87 MRGPRX4 (0.35) EGLN1THRATHRBMRGPRX4PDE4A
SCHEMBL4535685 0.87 THRA (0.38) MEN1KMT2ASMN1; SMN2THRATHRB
SCHEMBL4360211 0.86 MEN1 (0.39) MEN1KMT2ASMN1; SMN2THRATHRB
SCHEMBL4931128 0.86 MEN1 (0.37) MEN1KMT2ASMN1; SMN2THRATHRB
SCHEMBL4922892 0.85 THRB (0.50) THRATHRBDHODHMRGPRX4PTPN1
SCHEMBL4933712 0.85 EGLN1 (0.36) EGLN1MEN1KMT2ASMN1; SMN2THRA
SCHEMBL4926820 0.85 EGLN1 (0.38) EGLN1MEN1KMT2ASMN1; SMN2THRA
SCHEMBL4934946 0.84 SMN1; SMN2 (0.41) EGLN1MEN1KMT2ASMN1; SMN2THRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA EGLN1 2616/4885MEN1 773/4885KMT2A 1742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.